MARLBOROUGH, Mass.,
Nov. 5, 2020 /PRNewswire/
-- Boston Scientific Corporation (NYSE: BSX) will participate
in two upcoming virtual investor conferences.
On November 12, 2020, Meghan Scanlon, senior vice president and
president, Urology and Pelvic Health, and Susie Lisa, vice president, Investor Relations,
will participate in a 40-minute question-and-answer session with
the host analyst at the 29th Annual Credit Suisse
Virtual Healthcare Conference. The session will begin at
approximately 8:00 a.m. EST.
On November 18, 2020, Dan Brennan, executive vice president and chief
financial officer, and Susie Lisa
will participate in a 30-minute question-and-answer session with
the host analyst at the Stifel 2020 Virtual Healthcare Conference.
The session will begin at approximately 8:40
a.m. EST.
A live webcast and replay of the webcast for each event will be
accessible at
investors.bostonscientific.comhttp://www.bostonscientific.com/investors.
The replay will be available beginning approximately one hour
following the completion of each event.
About Boston Scientific
Boston Scientific transforms
lives through innovative medical solutions that improve the health
of patients around the world. As a global medical technology
leader for 40 years, we advance science for life by providing a
broad range of high performance solutions that address unmet
patient needs and reduce the cost of healthcare. For more
information, visit www.bostonscientific.com and connect on Twitter
and Facebook.
CONTACTS
Media:
|
Investors:
|
Katie
Schur
|
Susie Lisa,
CFA
|
508-683-5574
(office)
|
508-683-5565
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
Katie.Schur@bsci.com
|
BSXInvestorRelations@bsci.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/boston-scientific-announces-november-2020-conference-schedule-301166731.html
SOURCE Boston Scientific Corporation